{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:10:00Z","timestamp":1791609000175,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:00:00Z","timestamp":1432857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00431-015-2570-0","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T09:13:42Z","timestamp":1432804422000},"page":"855-865","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":209,"title":["Treatment of infantile haemangiomas: recommendations of a European expert group"],"prefix":"10.1007","volume":"174","author":[{"given":"Peter H.","family":"Hoeger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Baselga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence M.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Ciofi Degli","family":"Atti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"El Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold P.","family":"Oranje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta Troilius","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"L\u00e9aut\u00e9-Labr\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"2570_CR1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2014.01.905","volume":"70","author":"A \u00c1barz\u00faa-Araya","year":"2014","unstructured":"\u00c1barz\u00faa-Araya A, Navarrete-Dechent CP, Heusser F, Retamal J, Zegpi-Trueba MS (2014) Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. J Am Acad Dermatol 70:1045\u20139","journal-title":"J Am Acad Dermatol"},{"key":"2570_CR2","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/bjd.12432","volume":"169","author":"C Ahogo","year":"2013","unstructured":"Ahogo C, Ezzedine K, Prey S, Colona V, Diallo A, Boralevi F, Ta\u00efeb A, L\u00e9aut\u00e9-Labr\u00e8ze C (2013) Factors associated with the relapse of infantile haemangiomas in children treated with propranolol. Brit J Dermatol 169:1252\u20131256","journal-title":"Brit J Dermatol"},{"key":"2570_CR3","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1525-1470.2011.01644.x","volume":"28","author":"L Bagazgoitia","year":"2011","unstructured":"Bagazgoitia L, Hern\u00e1ndez-Mart\u00edn A, Torrelo A (2011) Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol 28:658\u2013662","journal-title":"Pediatr Dermatol"},{"key":"2570_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/S0022215112003192","volume":"127","author":"Y Bajaj","year":"2013","unstructured":"Bajaj Y, Kapoor K, Ifeacho S, Jephson CG, Albert DM, Harper JI, Hartley BE (2013) Great Ormond Street Hospital treatment guidelines for use of propranolol in infantile isolated subglottic haemangioma. J Laryngol Otol 127:295\u2013298","journal-title":"J Laryngol Otol"},{"key":"2570_CR5","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PRS.0b013e318208d2ac","volume":"127","author":"CG Bauland","year":"2011","unstructured":"Bauland CG, Luning TH, Smit JM, Zeebregts CJ, Spauwen PH (2011) Untreated hemangiomas: growth pattern and residual lesions. Plastic Reconstr Surg 127:1643\u20131648","journal-title":"Plastic Reconstr Surg"},{"key":"2570_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamaoto.2013.6723","volume":"140","author":"NM Bauman","year":"2014","unstructured":"Bauman NM, Shin JJ, Oh AK, Preciado DA, He J, Greene EA, Puttgen KB (2014) Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol, Head and Neck Surg 140:323\u201330","journal-title":"JAMA Otolaryngol, Head and Neck Surg"},{"key":"2570_CR7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/pde.12344","volume":"31","author":"F Blei","year":"2014","unstructured":"Blei F, McElhinney DB, Guarini A, Presti S (2014) Cardiac screening in infants with infantile hemangiomas before propranolol treatment. Pediatr Dermatol 31:465\u2013467","journal-title":"Pediatr Dermatol"},{"key":"2570_CR8","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archderm.144.12.1632","volume":"144","author":"HA Brandling-Bennett","year":"2008","unstructured":"Brandling-Bennett HA, Metry DW, Baselga E, Lucky AW, Adams DM, Cordisco MR, Frieden IJ (2008) Infantile hemangiomas with unusually prolonged growth phase: a case series. Arch Dermatol 144:1632\u20131637","journal-title":"Arch Dermatol"},{"key":"2570_CR9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-1470.2010.01224.x","volume":"28","author":"JM Breur","year":"2011","unstructured":"Breur JM, de Graaf M, Breugem CC, Pasmans SG (2011) Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report. Pediatr Dermatol 28:169\u2013171","journal-title":"Pediatr Dermatol"},{"key":"2570_CR10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jpeds.2007.04.055","volume":"151","author":"SL Chamlin","year":"2007","unstructured":"Chamlin SL, Haggstrom AN, Drolet BA, Baselga E, Frieden IJ, Garzon MC, Horii KA, Lucky AW, Metry DW, Newell B, Nopper AJ, Mancini AJ (2007) Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151:684\u2013689","journal-title":"J Pediatr"},{"key":"2570_CR11","doi-asserted-by":"crossref","first-page":"e1739","DOI":"10.1542\/peds.2012-3828","volume":"131","author":"H Chan","year":"2013","unstructured":"Chan H, McKay C, Adams S, Wargon O (2013) RCT of timolol maleate gel for superficial infantile hemangiomas in 5\u201324 week-olds. Pediatrics 131:e1739\u20131747","journal-title":"Pediatrics"},{"key":"2570_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1542\/peds.2012-1128","volume":"131","author":"TS Chen","year":"2013","unstructured":"Chen TS, Eichenfield LF, Friedlander SF (2013) Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics 131:99\u2013108","journal-title":"Pediatrics"},{"key":"2570_CR13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12835","volume":"171","author":"I Colmenero","year":"2014","unstructured":"Colmenero I, Hoeger PH (2014) Vascular tumours in infants. Part II: vascular tumours of intermediate dignity and malignant tumours. Brit J Dermatol 171:474\u2013484","journal-title":"Brit J Dermatol"},{"key":"2570_CR14","unstructured":"Del Frari L. Delarue A (2013) Data on file (Pierre Fabre). Presented at World Congress of Paediatric Dermatology, Madrid, 2013"},{"key":"2570_CR15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1525-1470.2011.01568.x","volume":"28","author":"P Dickison","year":"2011","unstructured":"Dickison P, Christou E, Wargon O (2011) A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol 28:663\u2013669","journal-title":"Pediatr Dermatol"},{"key":"2570_CR16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpeds.2008.05.043","volume":"153","author":"BA Drolet","year":"2008","unstructured":"Drolet BA, Swanson EA, Frieden IJ, Hemangioma Investigator Group (2008) Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 153:712\u20135","journal-title":"J Pediatr"},{"key":"2570_CR17","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/archdermatol.2010.1295","volume":"146","author":"BA Drolet","year":"2010","unstructured":"Drolet BA, Frieden IJ (2010) Characteristics of infantile hemangiomas as clue to pathogenesis: does hypoxia connect the dots? Arch Dermatol 146:1295\u20131299","journal-title":"Arch Dermatol"},{"key":"2570_CR18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","volume":"131","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Frommelt PC, Chamlin SI, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L, MacLellan-Tobert S, Mancini AJ, Metry D, Puttgen KB, Seefeldt M, Sidbury R, Ward KM, Blei F, Baselga E, Cassidy L, Darrow DH, Joachim S, Kwon EK, Martin K, Perkins J, Siegel DH, Boucek RJ, Frieden IJ (2013) Initiation and use of propranolol for infantile haemangioma: report of a consensus conference. Pediatrics 131:128\u2013140","journal-title":"Pediatrics"},{"key":"2570_CR19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","volume":"163","author":"L Filippi","year":"2013","unstructured":"Filippi L, Cavallaro G, Bagnoli P, Dal Monte M, Fiorini P, Donzelli G, Tinelli F, Araimo G, Cristofori G, la Marca G, Della Bona ML, La Torre A, Fortunato P, Furlanetto S, Osnaghi S, Mosca F (2013) Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives. J Pediatr 163:1570\u20131577","journal-title":"J Pediatr"},{"key":"2570_CR20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/MOP.0b013e32832ff3a7","volume":"21","author":"EH Garin","year":"2009","unstructured":"Garin EH, Araya CE (2009) Treatment of systemic hypertension in children and adolescents. Curr Opin Pediatr 21:600\u2013604","journal-title":"Curr Opin Pediatr"},{"key":"2570_CR21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/pde.12239","volume":"31","author":"A Giachetti","year":"2014","unstructured":"Giachetti A, Garcia-Monaco R, Sojo M, Scacchi MF, Cernadas C, Guerchicoff Lemcke M, Dovasio F (2014) Long-term treatment with oral propranolol reduces relapses of infantile hemangiomas. Pediatr Dermatol 31:14\u201320","journal-title":"Pediatr Dermatol"},{"key":"2570_CR22","author":"M Gnarra","year":"2015","unstructured":"Gnarra M, Solman L, Harper JI, Syed SB (2015) Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome. Br J Dermatol. doi: 10.1111\/bjd.13588 , Epub ahead of print","journal-title":"Br J Dermatol"},{"key":"2570_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjd.12435","volume":"169","author":"S Greenberger","year":"2013","unstructured":"Greenberger S, Bischoff J (2013) Pathogenesis of infantile haemangioma. Brit J Dermatol 169:12\u201319","journal-title":"Brit J Dermatol"},{"key":"2570_CR24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.2006-0413","volume":"118","author":"AN Haggstrom","year":"2006","unstructured":"Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ (2006) Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 118:882\u2013887","journal-title":"Pediatrics"},{"key":"2570_CR25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpeds.2006.12.003","volume":"150","author":"AN Haggstrom","year":"2007","unstructured":"Hemangioma Investigator Group, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Newell B, Nopper AJ, Frieden IJ (2007) Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 150:291\u2013294","journal-title":"J Pediatr"},{"key":"2570_CR26","doi-asserted-by":"crossref","unstructured":"Hengst M, Oelert M, Hoeger PH (2015) Blood pressure monitoring during the induction and maintenance period of propranolol therapy for complicated infantile haemangiomas. A prospective study of 109 infants. Pediatr Dermatol 2015, in press","DOI":"10.1111\/pde.12681"},{"key":"2570_CR27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1684\/ejd.2008.0576","volume":"19","author":"DJ Hermans","year":"2009","unstructured":"Hermans DJ, Boezeman JB, Van de Kerkhof PC, Rieu PN, Van der Vleuten CJ (2009) Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases. Eur J Dermatol 19:152\u2013156","journal-title":"Eur J Dermatol"},{"key":"2570_CR28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjd.12189","volume":"168","author":"DJ Hermans","year":"2013","unstructured":"Hermans DJ, Bauland CG, Zweegers J, van Beynum IM, van der Vleuten CJ (2013) Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions. Brit J Dermatol 168:837\u2013843","journal-title":"Brit J Dermatol"},{"key":"2570_CR29","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1111\/j.1365-2230.2009.03221.x","volume":"34","author":"PH Hoeger","year":"2009","unstructured":"Hoeger PH, Maerker JM, Kienast AK, Syed SB, Harper JI (2009) Neonatal haemangiomatosis associated with placental chorangiomas: report of three cases and review of the literature. Clin Exp Dermatol 34:e78\u201380","journal-title":"Clin Exp Dermatol"},{"key":"2570_CR30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bjd.12650","volume":"171","author":"PH Hoeger","year":"2014","unstructured":"Hoeger PH, Colmenero I (2014) Vascular tumours in infants. Part I: benign vascular tumours other than haemangioma. Brit J Dermatol 171:466\u2013473","journal-title":"Brit J Dermatol"},{"key":"2570_CR31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjd.13535","volume":"172","author":"PH Hoeger","year":"2015","unstructured":"Hoeger PH (2015) Propranolol for infantile haemangiomas: certain chances, potential risks. Br J Dermatol 172:3\u20134","journal-title":"Br J Dermatol"},{"key":"2570_CR32","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","volume":"128","author":"M Hogeling","year":"2011","unstructured":"Hogeling M, Adas S, Wargon O (2011) A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 128:e259\u2013e266","journal-title":"Pediatrics"},{"key":"2570_CR33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archdermatol.2010.158","volume":"146","author":"KE Holland","year":"2010","unstructured":"Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA (2010) Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 146:775\u2013777","journal-title":"Arch Dermatol"},{"key":"2570_CR34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1525-1470.2011.01420.x","volume":"28","author":"KA Horii","year":"2011","unstructured":"Horii KA, Drolet BA, Frieden IJ, Baselga E, Chamlin SL, Haggstrom AN, Holland KE, Mancini AJ, McCuaig CC, Metry DW, Morel KD, Newell BD, Nopper AJ, Powell J, Garzon MC (2011) Hemangioma Investigator Group. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol 28:245\u2013253","journal-title":"Pediatr Dermatol"},{"key":"2570_CR35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00431-014-2403-6","volume":"174","author":"SR Janmohamed","year":"2015","unstructured":"Janmohamed SR, Madern GC, de Laat PCJ, Oranje AP (2015) Educational paper: pathogenesis of infantile haemangioma, an update 2014 (part I). Eur J Pediatr 174:97\u2013103","journal-title":"Eur J Pediatr"},{"key":"2570_CR36","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm.1877","volume":"14","author":"M Jinnin","year":"2008","unstructured":"Jinnin M, Medici D, Park L, Liu Y, Boscolo EB, Bischoff J, Boye E, Olsen BR (2008) Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14:1236\u20131246","journal-title":"Nat Med"},{"key":"2570_CR37","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00431-013-2075-7","volume":"172","author":"S Kagami","year":"2013","unstructured":"Kagami S, Kuwano Y, Shibata S, Uwajima Y, Yamada D, Miyamoto A, Miyagawa T, Araki M, Takahashi K, Isomura S, Aozasa N, Masui Y, Yamamoto M, Inuzuka R, Katori T, Sato S (2013) Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas. Eur J Pediatr 172:1521\u20131526","journal-title":"Eur J Pediatr"},{"key":"2570_CR38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/pde.12023","volume":"30","author":"S Kaylani","year":"2013","unstructured":"Kaylani S, Theos AJ, Pressey JG (2013) Treatment of infantile hemangiomas with sirolimus in a patient with PHACE syndrome. Pediatr Dermatol 30:194\u20137","journal-title":"Pediatr Dermatol"},{"key":"2570_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13379","volume":"172","author":"A Langley","year":"2015","unstructured":"Langley A, Pope B (2015) Propranolol and central nervous system function: potential implications for pediatric patients with infantile hemangiomas. Br J Dermatol 172:13\u201323","journal-title":"Br J Dermatol"},{"key":"2570_CR40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Febrer Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ (2015) A randomized controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 372:735\u201346","journal-title":"N Engl J Med"},{"key":"2570_CR41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/pde.12182","volume":"30","author":"LS Liu","year":"2013","unstructured":"Liu LS, Sokoloff D, Antaya RJ (2013) Twenty-four-hour hospitalization for patients initiating systemic propranololtherapy for infantile hemangiomas\u2014is it indicated? Pediatr Dermatol 30:554\u2013560","journal-title":"Pediatr Dermatol"},{"key":"2570_CR42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12436","volume":"169","author":"M Luu","year":"2013","unstructured":"Luu M, Frieden IJ (2013) Haemangioma: clinical course, complications and management. Brit J Dermatol 169:20\u201330","journal-title":"Brit J Dermatol"},{"key":"2570_CR43","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jpedsurg.2013.08.020","volume":"48","author":"MA Malik","year":"2013","unstructured":"Malik MA, Menon P, Rao KL, Samujh R (2013) Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study. J Pediatr Surg 48:2453\u20132459","journal-title":"J Pediatr Surg"},{"key":"2570_CR44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/pde.12089","volume":"30","author":"AL Marqueling","year":"2013","unstructured":"Marqueling AL, Oza V, Frieden IJ, Puttgen KB (2013) Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol 30:182\u2013191","journal-title":"Pediatr Dermatol"},{"key":"2570_CR45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(90)90092-G","volume":"46","author":"J McAinsh","year":"1990","unstructured":"McAinsh J, Cruickshank JM (1990) Beta-blockers and central nervous system side effects. Pharmacol Ther 46:163\u201397","journal-title":"Pharmacol Ther"},{"key":"2570_CR46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1525-1470.2011.01685.x","volume":"29","author":"P McMahon","year":"2012","unstructured":"McMahon P, Oza V, Frieden IJ (2012) Topical timolol for infantile hemangiomas: putting a note of caution in \u201ccautiously optimistic\u201d. Pediatr Dermatol 29:127\u2013130","journal-title":"Pediatr Dermatol"},{"key":"2570_CR47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1525-1470.2012.01879.x","volume":"30","author":"D Metry","year":"2013","unstructured":"Metry D, Frieden IJ, Hess C, Siegel D, Maheshwari M, Baselga E, Chamlin S, Garzon M, Mancini AJ, Powell J, Drolet BA (2013) Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 30:71\u201389","journal-title":"Pediatr Dermatol"},{"issue":"suppl. 1","key":"2570_CR48","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0560.2010.01521.x","volume":"37","author":"MC Mihm","year":"2010","unstructured":"Mihm MC, Nelson JS (2010) Hypothesis: the metastatic niche theory can elucidate infantile hemangioma development. J Cutan Pathol 37(suppl 1):83\u201387","journal-title":"J Cutan Pathol"},{"key":"2570_CR49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/bjd.12804","volume":"170","author":"A Munden","year":"2014","unstructured":"Munden A, Butschek R, Tom WL, Marshall JS, Poeltler DM, Krohne SE, Ali\u00f3 AB, Ritter M, Friedlander DF, Catanzarite V, Mendoza A, Smith L, Friedlander M, Friedlander SF (2014) Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Brit J Dermatol 170:907\u2013913","journal-title":"Brit J Dermatol"},{"key":"2570_CR50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamaoto.2013.1218","volume":"139","author":"S Parikh","year":"2013","unstructured":"Parikh S, Darrow DH, Grimmer JF, Manning SC (2013) Propranolol use for infantile hemangiomas. American Society of Pediatric Otolaryngology Vascular Anomalies Task Force Practice Patterns. JAMA Otolaryngol Head Neck Surg 139:153\u2013156","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2570_CR51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2012.11131.x","volume":"168","author":"E Pope","year":"2013","unstructured":"Pope E, Chakkittakandiyil A, Lara-Corrales I, Maki E, Weinstein M (2013) Br J Dermatol 168:222\u20134","journal-title":"Br J Dermatol"},{"key":"2570_CR52","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archdermatol.2011.203","volume":"147","author":"CJ Price","year":"2011","unstructured":"Price CJ, Lattouf C, Baum B, McLeod MB, Schachner LA, Duarte AM, Connelly EA (2011) Propranolol vs. corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol 147:1371\u20131376","journal-title":"Arch Dermatol"},{"key":"2570_CR53","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00431-011-1671-7","volume":"171","author":"KB Puttgen","year":"2012","unstructured":"Puttgen KB (2012) Multifocal infantile hepatic hemangiomas\u2014imaging strategy and response to treatment after propranolol and steroids including review of the literature. Eur J Pediatr 171:1023\u20138","journal-title":"Eur J Pediatr"},{"key":"2570_CR54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/000348941312200903","volume":"122","author":"KB Puttgen","year":"2013","unstructured":"Puttgen KB, Summerer B, Schneider J, Cohen BA, Boss EF, Bauman NM (2013) Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas. Ann Otol Rhinol Laryngol 122:550\u2013554","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2570_CR55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.annder.2014.04.111","volume":"141","author":"W Saidi","year":"2014","unstructured":"Saidi W, Zaouali A, Saihi N, Mokni S, Denguezli M, Nouira R (2014) Arr\u00eat cardiorespiratoire au d\u00e9cours d\u2019une bronchiolite chez un nourisson trait\u00e9 par propranolol pour un h\u00e9mangiome. Ann Dermatol Venereol 141:528\u2013530","journal-title":"Ann Dermatol Venereol"},{"key":"2570_CR56","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/archdischild-2014-306514","volume":"99","author":"L Solman","year":"2014","unstructured":"Solman L, Murabit A, Gnarra M, Harper JI, Syed SB, Glover M (2014) Propranolol for infantile haemangiomas; single centre experience of 250 cases and proposed therapeutic protocol. Arch Dis Child 99:1132\u20131136","journal-title":"Arch Dis Child"},{"key":"2570_CR57","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1542\/peds.2011-3683","volume":"130","author":"MM Tollefson","year":"2012","unstructured":"Tollefson MM, Frieden IJ (2012) Early growth of infantile hemangiomas: what parents\u2019 photographs tell us. Pediatrics 130:e314\u201320","journal-title":"Pediatrics"},{"key":"2570_CR58","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000337253","volume":"78","author":"G Vergine","year":"2012","unstructured":"Vergine G, Marsciani A, Pedini A, Brocchi S, Marsciani M, Desiderio E, Bertelli S, Vecchi V (2012) Efficacy of propranolol treatment in thyroid dysfunction associated with severe infantile hepatichaemangioma. Horm Res Paediatr 78:256\u201360","journal-title":"Horm Res Paediatr"},{"key":"2570_CR59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/bjd.12229","volume":"169","author":"AD Vredenborg","year":"2013","unstructured":"Vredenborg AD, Janmohamed SR, de Laat PCJ, Madern GC, Oranje AP (2013) Multiple cutaneous infantile haemangiomas and the risk of internal haemangioma. Brit J Dermatol 169:188\u2013191","journal-title":"Brit J Dermatol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-015-2570-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-015-2570-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T15:35:05Z","timestamp":1599060905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-015-2570-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2570"],"URL":"https:\/\/doi.org\/10.1007\/s00431-015-2570-0","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,29]]}}}